JP2011513759A5 - - Google Patents

Download PDF

Info

Publication number
JP2011513759A5
JP2011513759A5 JP2010550179A JP2010550179A JP2011513759A5 JP 2011513759 A5 JP2011513759 A5 JP 2011513759A5 JP 2010550179 A JP2010550179 A JP 2010550179A JP 2010550179 A JP2010550179 A JP 2010550179A JP 2011513759 A5 JP2011513759 A5 JP 2011513759A5
Authority
JP
Japan
Prior art keywords
seq
polypeptide
antibody
ebv
vitro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010550179A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011513759A (ja
JP5592277B2 (ja
Filing date
Publication date
Priority claimed from EP08290224A external-priority patent/EP2101177A1/en
Application filed filed Critical
Publication of JP2011513759A publication Critical patent/JP2011513759A/ja
Publication of JP2011513759A5 publication Critical patent/JP2011513759A5/ja
Application granted granted Critical
Publication of JP5592277B2 publication Critical patent/JP5592277B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010550179A 2008-03-10 2009-03-10 エプスタイン−バーウイルス(ebv)再活性化のインビトロ診断のためのzebraタンパク質由来合成ペプチドの使用 Expired - Fee Related JP5592277B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08290224A EP2101177A1 (en) 2008-03-10 2008-03-10 Use of synthetic peptide derived from zebra protein for the in vitro diagnosis of the epstein-barr virus (EBV) reactivation
EP08290224.8 2008-03-10
PCT/EP2009/052798 WO2009112497A1 (en) 2008-03-10 2009-03-10 Use of synthetic peptide derived from zebra protein for the in vitro diagnosis of the epstein-barr virus (ebv) reactivation

Publications (3)

Publication Number Publication Date
JP2011513759A JP2011513759A (ja) 2011-04-28
JP2011513759A5 true JP2011513759A5 (https=) 2011-06-16
JP5592277B2 JP5592277B2 (ja) 2014-09-17

Family

ID=39595705

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010550179A Expired - Fee Related JP5592277B2 (ja) 2008-03-10 2009-03-10 エプスタイン−バーウイルス(ebv)再活性化のインビトロ診断のためのzebraタンパク質由来合成ペプチドの使用

Country Status (9)

Country Link
US (1) US20110076671A1 (https=)
EP (2) EP2101177A1 (https=)
JP (1) JP5592277B2 (https=)
CN (1) CN102016586B (https=)
AT (1) ATE530913T1 (https=)
CA (1) CA2718245C (https=)
ES (1) ES2375095T3 (https=)
MY (1) MY156432A (https=)
WO (1) WO2009112497A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2983482B1 (fr) * 2011-12-05 2017-10-20 Univ Joseph Fourier Utilisation d'au moins un biomarqueur pour le pronostic ou le diagnostic in vitro d'episodes lymphoproliferatifs associes au virus d'epstein-barr (ebv)
WO2014025254A1 (en) 2012-08-10 2014-02-13 Stichting Vu-Vumc Ebv markers and systemic lupus erythematosus
CN109679975B (zh) * 2019-01-23 2020-12-08 济宁医学院 一种改造bzlf1和改造lmp1的融合基因及其应用
CN113061165B (zh) * 2020-01-02 2026-04-21 厦门大学 EB病毒BNLF2b基因编码多肽及其检测用途
CN111826412A (zh) * 2020-06-02 2020-10-27 中山大学肿瘤防治中心(中山大学附属肿瘤医院、中山大学肿瘤研究所) 一种高通量检测eb病毒感染效率/抗体阻断eb病毒感染效率的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE428724T1 (de) * 1992-09-15 2009-05-15 Ortho Diagnostic Systems Inc Immunreaktive peptide des epstein-barrvirus
FR2728904B1 (fr) * 1995-01-04 1997-03-14 Pasteur Institut Reactif peptidique permettant de detecter une infection primaire a virus d'epstein-barr par recherche des anticorps correspondants, et procede d'utilisation de ce reactif
PT747481E (pt) * 1995-06-06 2002-05-31 Organon Teknika Bv Peptidos do virus de epstein-barr e anticorpos contra estes peptidos
JPH11511853A (ja) * 1996-03-29 1999-10-12 オルソ ダイアグノスティック システムズ インク エプスタイン・バーウイルス関連疾患の診断法
FR2791142B1 (fr) * 1999-03-17 2001-06-22 Univ Grenoble 1 Utilisation de la brefeldine a pour augmenter l'effet de presentation d'antigenes exogenes par les cpa
JP5492418B2 (ja) * 2005-11-18 2014-05-14 ザ オハイオ ステート ユニバーシティー リサーチ ファウンデーション ウイルス関連疾患を予防するためのウイルス遺伝子産物およびワクチン接種の方法

Similar Documents

Publication Publication Date Title
JP2012115275A5 (https=)
JP2013508739A5 (https=)
Chin et al. Dual-enhanced plasmonic biosensing for point-of-care sepsis detection
JP2013516633A5 (https=)
JP2011513759A5 (https=)
SI2524060T1 (en) Investigation for JC virus antibodies
JP2012509295A5 (https=)
JP2010526880A5 (https=)
JP2014521089A5 (https=)
JP2012143232A5 (https=)
JP2010516678A5 (https=)
JP2012509477A5 (https=)
JP2010207229A5 (https=)
JP2013539032A5 (https=)
JP2012522232A5 (https=)
JP2012501318A5 (https=)
Foster et al. Targeted proteomics of human metapneumovirus in clinical samples and viral cultures
RU2012148244A (ru) Способ диагностики онкологических заболеваний и иммуноферментный набор для его осуществления
CN105675863A (zh) 一组耐多药结核病诊断标志物及其用途
CN102586157A (zh) 一种高通量富集、捕获副溶血性弧菌的方法
WO2011118982A3 (ko) 융합 폴리펩타이드 hpv 항원을 이용한 hpv 항체 스크리닝 방법
RU2014114532A (ru) Способ измерения антитела против wt1
CN203909043U (zh) 一种同时检测多种自身免疫性抗体的芯片
CA2837522A1 (en) Biomarkers for autoimmune liver diseases and uses thereof
CN102236016A (zh) 用于检测干燥综合症α-胞衬蛋白抗体的胶体金检测卡